Proton magnetic resonance spectroscopic imaging in brain tumor diagnosis.

The current state of standard tumor diagnostics using contrast-enhanced MRI and biopsy is assessed in this review, and the progress of proton magnetic resonance spectroscopy (MRS) over the last 15 years is discussed. We summarize MRS basics and describe a typical magnetic resonance session for noninvasive routine tumor diagnostics at 1.5 T, including two-dimensional magnetic resonance spectroscopic imaging (MRSI). The results that can be obtained from such procedures are illustrated with clinical examples. Attention is turned to cutting-edge methodologic and clinical research at 3 T, with examples using high-resolution or very short echo-time three-dimensional MRSI. The current status and limitations in proton MRSI are discussed, and we look to the potential of faster data collection and even higher field strength.

[1]  G J Barker,et al.  Quantitative analysis of short echo time 1H‐MRSI of cerebral gray and white matter , 2000, Magnetic resonance in medicine.

[2]  M. Bernstein,et al.  Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. , 1994, Journal of neurosurgery.

[3]  C. Strauss,et al.  Magnetic source imaging combined with image-guided frameless stereotaxy: a new method in surgery around the motor strip. , 1997, Neurosurgery.

[4]  Mauricio Castillo,et al.  MR spectroscopy of brain tumors. , 2003, Magnetic resonance imaging clinics of North America.

[5]  Robin A. de Graaf.  In vivo NMR spectroscopy , 1998 .

[6]  E Moser,et al.  Proton T 1 and T 2 relaxation times of human brain metabolites at 3 Tesla , 2001, NMR in biomedicine.

[7]  C. Matula,et al.  Contour-guided brain tumor surgery using a stereotactic navigating microscope. , 1997, Stereotactic and functional neurosurgery.

[8]  Peter Boesiger,et al.  Parallel spectroscopic imaging with spin‐echo trains , 2003, Magnetic resonance in medicine.

[9]  R Gruetter,et al.  Automatic, localized in Vivo adjustment of all first‐and second‐order shim coils , 1993, Magnetic resonance in medicine.

[10]  M. Berger,et al.  Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. , 2002, Journal of neurosurgery.

[11]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[12]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[13]  Sylvie Grand,et al.  A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images , 2000, Nature Medicine.

[14]  E. Shoubridge,et al.  Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading , 1990, NMR in biomedicine.

[15]  R Kasrai,et al.  Magnetic Resonance Spectroscopy Guided Brain Tumor Resection: Differentiation Between Recurrent Glioma and Radiation Change in Two Diagnostically Difficult Cases , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  P R Luyten,et al.  Detection of metabolic heterogeneity of human intracranial tumors in vivo by 1h nmr spectroscopic imaging , 1990, Magnetic resonance in medicine.

[17]  J. Frahm,et al.  On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro , 1992, NMR in biomedicine.

[18]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[19]  V. L. Doyle,et al.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.

[20]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[21]  J. Hainfellner,et al.  Frameless stereotactic-directed tissue sampling during surgery of suspected low-grade gliomas to avoid histological undergrading. , 1998, Minimally invasive neurosurgery : MIN.

[22]  E Moser,et al.  Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. , 2001, AJNR. American journal of neuroradiology.

[23]  I. Smith,et al.  Magnetic resonance spectroscopy in biology and medicine. , 1989, Clinical biochemistry.

[24]  W. Paulus,et al.  Intratumoral histologic heterogeneity of gliomas. A quantitative study , 1989, Cancer.

[25]  Quanjun Zhao,et al.  Stereotactic Biopsy for Intracranial Space-Occupying Lesions: Clinical Analysis of 550 Cases , 2001, Stereotactic and Functional Neurosurgery.

[26]  M. Castillo,et al.  Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. , 1998, Magnetic resonance imaging clinics of North America.

[27]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[28]  Irina Mader,et al.  Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors , 1996, Magnetic Resonance Materials in Physics, Biology and Medicine.

[29]  Witham,et al.  Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. , 2001, Journal of neurosurgery.

[30]  J E Heiserman,et al.  Effect of voxel position on single-voxel MR spectroscopy findings. , 2000, AJNR. American journal of neuroradiology.

[31]  A Haase,et al.  Localization of unaffected spins in NMR imaging and spectroscopy (LOCUS spectroscopy) , 1986, Magnetic resonance in medicine.

[32]  Mauricio Castillo,et al.  Clinical Applications of Proton MR Spectroscopy in Oncology , 2002, Technology in cancer research & treatment.

[33]  B. Ross,et al.  Clinical Applications of Magnetic Resonance Spectroscopy , 1997, Epilepsia.

[34]  H. Kober,et al.  Functional and metabolic analysis of cerebral ischemia using magnetoencephalography and proton magnetic resonance spectroscopy , 1997, Annals of neurology.

[35]  G. Kemp,et al.  Quantification of Metabolic Differences in the Frontal Brain of Depressive Patients and Controls Obtained by 1H-MRS at 3 Tesla , 2003, Investigative radiology.

[36]  M P Carol,et al.  MR-spectroscopy guided target delineation for high-grade gliomas. , 2001, International journal of radiation oncology, biology, physics.

[37]  Daniel B Vigneron,et al.  In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI , 2002, Journal of magnetic resonance imaging : JMRI.

[38]  Ewald Moser,et al.  High‐resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy‐matched voxel sizes , 2003, Magnetic resonance in medicine.

[39]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[40]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[41]  Andreas Ebel,et al.  Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy. , 2003, Magnetic resonance imaging.

[42]  Gioacchino Tedeschi,et al.  High Speed 1H Spectroscopic Imaging in Human Brain by Echo Planar Spatial‐Spectral Encoding , 1995, Magnetic resonance in medicine.

[43]  Yu-Chung N. Cheng,et al.  Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .

[44]  B Vikhoff-Baaz,et al.  Effects of k-space filtering and image interpolation on image fidelity in (1)H MRSI. , 2001, Magnetic resonance imaging.

[45]  D. Arnold,et al.  Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors , 1998, NMR in biomedicine.

[46]  A. Muacevic,et al.  The Risk of Haemorrhage after Image Guided Stereotactic Biopsy of Intra-Axial Brain Tumours – A Prospective Study , 2001, Acta Neurochirurgica.

[47]  P. Jannin,et al.  A data fusion environment for multimodal and multi-informational neuronavigation. , 2000, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.

[48]  J. Torner,et al.  Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. , 1998, Surgical neurology.

[49]  S. Holtås,et al.  Proton magnetic resonance spectroscopy in brain tumours: clinical applications , 2001, Neuroradiology.

[50]  J Star-Lack,et al.  High spatial resolution and speed in MRSI , 1997, NMR in biomedicine.

[51]  Edward E Graves,et al.  Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. , 2002, International journal of radiation oncology, biology, physics.

[52]  Franklyn A Howe,et al.  1H MR spectroscopy of brain tumours and masses , 2003, NMR in biomedicine.

[53]  M A Jacobs,et al.  Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem , 2001, Magnetic resonance in medicine.

[54]  D. Vigneron,et al.  An automated technique for the quantitative assessment of 3D‐MRSI data from patients with glioma , 2001, Journal of magnetic resonance imaging : JMRI.

[55]  P Sabbah,et al.  Multimodal anatomic, functional, and metabolic brain imaging for tumor resection. , 2002, Clinical imaging.

[56]  C. Nimsky,et al.  Integration of functional magnetic resonance imaging supported by magnetoencephalography in functional neuronavigation , 1999, Neurosurgery.

[57]  F. Mihara,et al.  MR imaging of adult supratentorial astrocytomas: an attempt of semi-automatic grading. , 1995, Radiation medicine.

[58]  C. Matula,et al.  Histological heterogeneity of neuroradiologically suspected adult low grade gliomas detected by Xenon enhanced computerized tomography (CT) , 2005, Acta Neurochirurgica.

[59]  Markus Barth,et al.  High-Resolution Three-Dimensional Contrast-Enhanced Blood Oxygenation Level-Dependent Magnetic Resonance Venography of Brain Tumors at 3 Tesla: First Clinical Experience and Comparison with 1.5 Tesla , 2003, Investigative radiology.

[60]  Carles Arús,et al.  Automated classification of short echo time in in vivo 1H brain tumor spectra: A multicenter study , 2003, Magnetic resonance in medicine.

[61]  M Ala-Korpela,et al.  Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.

[62]  Christopher Nimsky,et al.  Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. , 2004, Journal of neurosurgery.

[63]  W. Hall,et al.  Improving diagnostic yield in brain biopsy: Coupling spectroscopic targeting with real‐time needle placement , 2001, Journal of magnetic resonance imaging : JMRI.

[64]  David Hearshen,et al.  Correlations between Magnetic Resonance Spectroscopy and Image-guided Histopathology, with Special Attention to Radiation Necrosis , 2002, Neurosurgery.

[65]  B. Drayer,et al.  Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy. , 1986, Radiology.

[66]  K. Uğurbil,et al.  Ultrahigh field magnetic resonance imaging and spectroscopy. , 2003, Magnetic resonance imaging.

[67]  T. Mikkelsen,et al.  Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated Glioma , 2001, Neurosurgery.

[68]  Use of a neural network and a multiple regression model to predict histologic grade of astrocytoma from MRI appearances , 1995, Neuroradiology.

[69]  F. Alesch,et al.  The role of stereotactic biopsy in radiosurgery. , 1995, Acta neurochirurgica. Supplement.

[70]  A. Falini,et al.  Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives , 1996, Journal of Neurology.

[71]  R Steinmeier,et al.  Functional neuronavigation with magnetoencephalography: outcome in 50 patients with lesions around the motor cortex. , 1999, Neurosurgical focus.

[72]  Glyn Johnson,et al.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.

[73]  Ying Lu,et al.  Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.

[74]  Bernard Gibaud,et al.  Integration of sulcal and functional information for multimodal neuronavigation. , 2002, Journal of neurosurgery.

[75]  R. L. Kamman,et al.  Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography , 1995, Neuroradiology.

[76]  Ewald Moser,et al.  Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas , 2004, NeuroImage.